Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma

• Verfasst von: Huang, Lei [VerfasserIn]
• Verfasst von: Balavarca, Yesilda [VerfasserIn]
• Verfasst von: Schrotz-King, Petra [VerfasserIn]
• Verfasst von: Brenner, Hermann [VerfasserIn]
• Titel: Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma
• Titelzusatz: a large international population-based cohort study
• Verf.angabe: Lei Huang, Yesilda Balavarca, Lydia van der Geest, Valery Lemmens, Liesbet Van Eycken, Harlinde De Schutter, Tom B. Johannesen, Vesna Zadnik, Maja Primic-Žakelj, Margit Mägi, Robert Grützmann, Marc G. Besselink, Petra Schrotz-King, Hermann Brenner and Lina Jansen
• E-Jahr: 2019
• Jahr: 25 March 2019
• Umfang: 16 S.
• Fussnoten: Gesehen am 08.04.2019
• Titel Quelle: Enthalten in: BMC medicine
• Ort Quelle: London : BioMed Central, 2003
• Jahr Quelle: 2019
• Band/Heft Quelle: 17(2019) Artikel-Nummer 66, 16 Seiten
• ISSN Quelle: 1741-7015
• DOI: doi:10.1186/s12916-019-1304-y
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1662971079

Abstract

Pancreatic cancer (PaC) remains extremely lethal worldwide even after resection. PaC resection rates are low, making prognostic studies in resected PaC difficult. This large international population-based study aimed at exploring factors associated with survival in patients with resected TNM stage I-II PaC receiving chemotherapy and at developing and internationally validating a survival-predicting model.